Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
1MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences,University of Dundee, 2The Michael J. Fox Foundation for Parkinson’s Research, 3Department of Medical and Molecular Genetics,Indiana University School of Medicine, 4Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital,University of Toronto, 5Division of Cell Signalling and Immunology, School of Life Sciences,University of Dundee, 6Division of Molecular and Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School,University of Dundee
Chapitres
- 00:01Introduction
- 00:48Neutrophil Isolation from Human Peripheral Blood
- 07:18LRRK2 Kinase Inhibitor Treatment
- 10:33Résultats
- 12:14Conclusion
Mutationer i leucin rige gentage kinase 2 gen (LRRK2) forårsage arvelig Parkinsons sygdom. Vi har udviklet en nem og robust metode til vurdering af LRRK2-kontrolleret fosforylering af Rab10 hos menneskers perifere blodneutrofiler. Dette kan hjælpe med at identificere personer med øget LRRK2 kinase pathway aktivitet.
